161 related articles for article (PubMed ID: 4015025)
1. Variation of estrogen and progesterone receptor status in breast cancer.
Alanko A
Ann Clin Res; 1985; 17(1):10-4. PubMed ID: 4015025
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
3. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
4. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
[TBL] [Abstract][Full Text] [Related]
5. Progesterone and estrogen receptors as prognostic variables in breast cancer.
Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
[TBL] [Abstract][Full Text] [Related]
6. [Hormone receptors and breast cancer prognosis].
Saez S; Pichon MF
Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
[TBL] [Abstract][Full Text] [Related]
7. Effect of time and therapy on the hormone receptor status of breast carcinomas.
Mobbs BG
Can Med Assoc J; 1982 Aug; 127(3):217-21. PubMed ID: 6896673
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer.
Garimella V; Long ED; O'Kane SL; Drew PJ; Cawkwell L
Acta Oncol; 2007; 46(2):204-7. PubMed ID: 17453370
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
Vyzula R; Zaloudík J; Dusek L; Vermousek I
Neoplasma; 2001; 48(1):19-25. PubMed ID: 11327533
[TBL] [Abstract][Full Text] [Related]
10. [Progesterone receptors in breast cancer].
Vitola GIa; Zeĭkate GA; Grabovska IK
Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
12. Assay of estrogen and progesterone receptors in small samples of breast cancer: II. The conventional procedure compared to the mathematical one.
Viticchi C; Basso A; Piantanelli L; Zaia A
Boll Soc Ital Biol Sper; 1994; 70(8-9):229-34. PubMed ID: 7893481
[TBL] [Abstract][Full Text] [Related]
13. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
[TBL] [Abstract][Full Text] [Related]
14. Multiple or sequential oestrogen receptor assays in breast cancer.
Bennett RC; Mercer RJ; Lie TH
Aust N Z J Surg; 1983 Jun; 53(3):231-6. PubMed ID: 6576774
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor status of breast cancer metastases.
Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
[TBL] [Abstract][Full Text] [Related]
16. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
Izuo M; Iino Y
Gan No Rinsho; 1983 May; 29(6):637-43. PubMed ID: 6876433
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
18. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.
Oxley DK; Haven GT; Wittliff JL; Gilbo D
Am J Clin Pathol; 1982 Oct; 78(4 Suppl):587-96. PubMed ID: 7137099
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
